Dacliximab Biosimilar (Anti-IL-2Ra / CD25 Reference Antibody)

Biorbyt

Dacliximab Biosimilar (Anti-IL-2Ra / CD25 Reference Antibody)

10

Research Use Only

Monoclonal

Unconjugated

Daclizumab (Zenapax) is a humanized, monoclonal antibody that blocks CD25 (alpha-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab (Zenapax) reversibly binds to CD25and prevents the interaction of IL-2 with the IL-2R-HA. Daclizumab (Zenapax) can be used for multiple sclerosis research.

-20°C,2°C to 8°C

12352203